Literature DB >> 30327882

Pleuroparenchymal fibroelastosis as a histological background of autoimmune diseases.

Yoshiaki Kinoshita1,2, Kentaro Watanabe3,4, Hiroshi Ishii1, Hisako Kushima1, Makoto Hamasaki2, Masaki Fujita1, Kazuki Nabeshima2.   

Abstract

Patients with autoimmune disease-related interstitial lung disease (AID-ILD) occasionally develop radiologic pleuroparenchymal fibroelastosis (PPFE)-like lesions. However, the significance of AID as an etiology of PPFE has not been fully elucidated. The aim of this study is to verify the increase of elastic fibers in AID-ILD patients and evaluate the prevalence of histological PPFE in patients with AID-ILD. We selected cases of clinically diagnosed AID-ILD and idiopathic pulmonary fibrosis (IPF), in which an autopsy had been performed or in which the patient had undergone pneumonectomy for lung transplantation. We quantified the collagen fibers and elastic fibers in each lobe as the percentage of the non-aerated lung area (collagen fiber score and elastic fiber score, respectively) in histological specimens from a total of 73 patients (AID-ILD, n = 24; IPF, n = 49). There were no significant differences in the collagen fiber scores of the AID-ILD and IPF groups. Meanwhile, the elastic fiber scores of the AID-ILD group were significantly greater than those of the IPF group in the whole lung (17.3 ± 7.70 vs 11.6 ± 4.55), and the upper (16.6 ± 8.11 vs 11.2 ± 5.18), and lower (18.0 ± 9.68 vs 12.0 ± 5.55) lobes (all p < 0.01). Histological PPFE pattern was found in 12 of 24 AID-ILD patients (50%), and histological PPFE pattern as a dominant pattern of fibrosis was found in 2 of the 24 patients (8%). Thus, PPFE can be a manifestation of AID-ILD.

Entities:  

Keywords:  Connective tissue disease; Elastic fibers; Pleuroparenchymal fibroelastosis; Usual interstitial pneumonia; Vasculitis

Mesh:

Substances:

Year:  2018        PMID: 30327882     DOI: 10.1007/s00428-018-2473-3

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  33 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

Review 2.  Polymyositis and dermatomyositis (second of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-20       Impact factor: 91.245

Review 3.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-01-15       Impact factor: 21.405

Review 4.  Mechanisms and consequences of fibrosis in systemic sclerosis.

Authors:  Christopher P Denton; Carol M Black; David J Abraham
Journal:  Nat Clin Pract Rheumatol       Date:  2006-03

5.  2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovský; Frederick Wolfe; Gillian Hawker
Journal:  Arthritis Rheum       Date:  2010-09

6.  Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity.

Authors:  Stephen K Frankel; Carlyne D Cool; David A Lynch; Kevin K Brown
Journal:  Chest       Date:  2004-12       Impact factor: 9.410

7.  Connective tissue disease-associated interstitial lung disease: a call for clarification.

Authors:  Aryeh Fischer; Sterling G West; Jeffrey J Swigris; Kevin K Brown; Roland M du Bois
Journal:  Chest       Date:  2010-08       Impact factor: 9.410

8.  Idiopathic and collagen vascular disease nonspecific interstitial pneumonia: clinical significance of remodeling process.

Authors:  Carlos Henrique Chirnev Felício; Edwin Roger Parra; Vera Luiza Capelozzi
Journal:  Lung       Date:  2007-02-09       Impact factor: 2.584

Review 9.  Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project.

Authors:  William D Travis; Gary Hunninghake; Talmadge E King; David A Lynch; Thomas V Colby; Jeffrey R Galvin; Kevin K Brown; Man Pyo Chung; Jean-François Cordier; Roland M du Bois; Kevin R Flaherty; Teri J Franks; David M Hansell; Thomas E Hartman; Ella A Kazerooni; Dong Soon Kim; Masanori Kitaichi; Takashi Koyama; Fernando J Martinez; Sonoko Nagai; David E Midthun; Nestor L Müller; Andrew G Nicholson; Ganesh Raghu; Moisés Selman; Athol Wells
Journal:  Am J Respir Crit Care Med       Date:  2008-04-03       Impact factor: 21.405

Review 10.  Fibrosis in connective tissue disease: the role of the myofibroblast and fibroblast-epithelial cell interactions.

Authors:  Thomas Krieg; David Abraham; Robert Lafyatis
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  4 in total

1.  Pleuroparenchymal Fibroelastosis Associated with Crohn's Disease: A New Aetiology?

Authors:  Carolina Amado; Pedro Gonçalo Ferreira
Journal:  Eur J Case Rep Intern Med       Date:  2020-11-25

Review 2.  Pleuroparenchymal Fibroelastosis. A Review of Clinical, Radiological, and Pathological Characteristics.

Authors:  Felix Chua; Sujal R Desai; Andrew G Nicholson; Anand Devaraj; Elisabetta Renzoni; Alexandra Rice; Athol U Wells
Journal:  Ann Am Thorac Soc       Date:  2019-11

3.  The similarities and differences between pleuroparenchymal fibroelastosis and idiopathic pulmonary fibrosis.

Authors:  Hiroshi Ishii; Yoshiaki Kinoshita; Hisako Kushima; Nobuhiko Nagata; Kentaro Watanabe
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

4.  Pleuroparenchymal fibroelastosis in Korean patients: clinico-radiologic-pathologic features and 2-year follow-up.

Authors:  Jae Ha Lee; Eun Jin Chae; Joon Seon Song; Miae Kim; Jin Woo Song
Journal:  Korean J Intern Med       Date:  2020-02-24       Impact factor: 2.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.